June 19, 2024
by Andrii Buvailo
Biopharma insight
Foundation models represent a new paradigm in artificial intelligence (AI), revolutionizing how machine learning models are developed and deployed. As …
Aug. 4, 2024
by Andrii Buvailo, PhD
Biopharma insight
Brain-computer interface (BCI) technologies are rapidly becoming the spotlight of the neurotech industry, with Neuralink at the forefront. Recently, Neuralink …
July 23, 2024
by Andrii Buvailo, PhD
Interview
The rapid convergence of artificial intelligence (AI) and synthetic biology (synbio) is set to revolutionize a multitude of industries, ranging …
July 22, 2024
by Andrii Buvailo
Biopharma insight
If we talk about tech advances in pharma and biotech, the year 2024 has been a blast so far! Last …
July 19, 2024
by Andrii Buvailo, PhD
Biopharma insight
As the biotech sector recovers to pre-COVID investment levels, venture capital firms have become more selective in their funding choices. …
July 11, 2024
by Andrii Buvailo, PhD
Biopharma insight
Element Biosciences has raised over $277 million in a Series D funding round to further develop and commercialize its DNA …
June 27, 2024
by Andrii Buvailo
Biopharma insight
In 1986, Danish scientist Jens Juul Holst discovered that the gut hormone GLP-1 stimulates insulin and suppresses appetite. This research …
June 18, 2024
by Natalia Honchar
Biopharma insight
According to our intelligence report, The State of Artificial Intelligence (AI) in the Biopharma Industry, more than 450 life sciences …
June 16, 2024
by Andrii Buvailo
Biopharma insight
For many years the focus of therapeutic developments and scientific research was directed at the genome and proteins. Yet, there …
June 13, 2024
by Andrii Buvailo, PhD
Interview
Toronto-based “techbio” company Deep Genomics has just annouced major milestones with the opening of a new office and lab facility …
June 9, 2024
by Andrii Buvailo, PhD
Biopharma insight
Cyclic peptides, characterized by their unique ring structures, represent an emerging trend in drug discovery due to their ability to …
May 29, 2024
by Andrii Buvailo, PhD
Biopharma insight
For many years, the focus of therapeutic developments and scientific research was directed at the genome and proteins. Yet, there …